Mankind Pharma Limited is an Indian company in the pharmaceuticals & biotechnology industry (formerly Mankind Pharma Private Limited) with one outstanding bond (ISIN) recorded on this page. The bond has ISIN INE634S07033. It carries a stated coupon of 7.97% a year, matures on 16 Nov 2027 and had an issue size of ₹2,500 crore. NSDL records it as secured. Latest credit rating on record: CRISIL AA+ (Stable) (action dated 27 Sep 2024). Verify current terms against the official documents linked on this page.
Data as of 27 Oct 2026 · How this page is compiled
Issuer overview
- Legal name
- Mankind Pharma Limited
- Formerly
- Mankind Pharma Private Limited
- CIN
- L74899DL1991PLC044843
- LEI
- 33580067G8AZ7S8NYA02
- Industry
- Pharmaceuticals & Biotechnology
- Business
- Pharmaceuticals
- Ownership
- Non PSU
- ISIN issuer code
- INE634S
- Outstanding bonds (ISINs)
- 1 (plus 2 matured)
- Stated coupons (fixed rate)
- 7.97%
- Maturity dates
- 16 Nov 2027
- Secured (NSDL)
- 1 of 1
- Combined issue size of outstanding bonds
- ₹2,500 crore
Issue size is the amount each bond raised when it was issued, as recorded by NSDL. It is not the amount still outstanding today (bonds can be partly redeemed or bought back) and not the company's total debt.
Mankind Pharma bonds: ISIN, coupon and maturity
1 outstanding bond, by maturity date.
| ISIN | Coupon | Interest paid | Allotted | Maturity | Face value | Issue size (₹ cr) | Security | Guarantee | Rating (NSDL) |
|---|---|---|---|---|---|---|---|---|---|
| INE634S07033 | 7.97% | Yearly | 16 Oct 2024 | 16 Nov 2027 | ₹1,00,000 | 2,500 | Secured | None recorded | CRISIL AA+ 27 Sep 2024 |
- Outstanding means the maturity date has not passed, according to the depository record. It does not confirm that a bond has not been redeemed early, called or bought back.
- Type, coupon, interest frequency, allotment date, issue size, security and guarantee are as recorded by NSDL India Bond Info, the depository's record of each ISIN. Search an ISIN on NSDL India Bond Info to see its full record.
- "Secured" and "Guarantee" are NSDL's classification. What the security is, the asset cover and the terms of any guarantee or co-obligor are in the offer document and the debenture trust deed; this page does not infer them.
- Prices and yields are not shown. They change with every trade: see BSE and NSE.
Private placements and disclosure documents
| Allotted | ISIN | Redemption | Disclosure documents |
|---|---|---|---|
| 16 Oct 2024 | INE634S07025 | 16 Oct 2026 | Placement memorandum on BSE |
| 16 Oct 2024 | INE634S07033 | 16 Nov 2027 | Placement memorandum on BSE |
| 16 Oct 2024 | INE634S07017 | 16 Apr 2026 | Placement memorandum on BSE |
From BSE's list of privately placed debt. The documents are the issuer's own; the offer document and debenture trust deed are the authoritative source for each bond's terms.
Mankind Pharma bonds: questions and answers
What bonds has Mankind Pharma Limited issued?
Mankind Pharma Limited has one outstanding bond recorded on this page. 2 further ISINs on record have passed their maturity dates and are not counted as outstanding.
What is the ISIN of the Mankind Pharma Limited bond?
The bond recorded on this page has ISIN INE634S07033. Indian ISINs of the same issuer share the first seven characters (INE634S), the issuer code.
What is the coupon rate on the Mankind Pharma Limited bond?
Bond INE634S07033 carries a stated coupon of 7.97% a year, according to NSDL India Bond Info. The coupon is not the yield: the yield an investor earns depends on the price paid.
When does the Mankind Pharma Limited bond mature?
Bond INE634S07033 has a maturity date of 16 Nov 2027. It was allotted on 16 Oct 2024.
What is the latest CRISIL credit rating of Mankind Pharma Limited bonds?
NSDL India Bond Info records CRISIL AA+ (Stable) (action dated 27 Sep 2024) on its outstanding bonds. The latest action on record is more than 15 months old, so check the agency's website for a more recent rating. A rating is the agency's opinion and can change at any time.
Is the Mankind Pharma Limited bond secured, unsecured or guaranteed?
NSDL records bond INE634S07033 as secured and not guaranteed. What the security is, the asset cover and the terms of any guarantee or co-obligor are set out in the offer document and the debenture trust deed; this page does not infer them.
Is Mankind Pharma Limited the same company as Mankind Pharma Private Limited?
Yes. Mankind Pharma Limited was formerly known as Mankind Pharma Private Limited; bonds issued under the earlier name are obligations of the same company. Its Corporate Identification Number (CIN) is L74899DL1991PLC044843.
Where can investors find the original disclosure documents for Mankind Pharma Limited bonds?
Each ISIN's record, including its terms and rating history, is on NSDL India Bond Info (search the ISIN). The offer document (shelf prospectus, tranche prospectus or general information document and key information document) and the debenture trust deed set out the full terms; listed issuers publish them on BSE or NSE. For the private placements listed on this page, each row links to the disclosure documents on BSE.
How can investors check the current market price or yield of Mankind Pharma Limited bonds?
This page does not show prices or yields. Trades in these bonds are reported on BSE and NSE, which publish the price and yield of each trade, usually by the end of the trading day. Many corporate bonds trade rarely, so a recent price may not exist; an old trade is not a current price.
Sources and dates
- NSDL India Bond Info: bond terms, issuer identity and ratings by ISIN
- BSE and NSE: bonds that have traded, and their exchange listings
- BSE: privately placed debt securities
- Methodology: how these pages are compiled and checked
Data as of 27 Oct 2026. Facts on this page last changed on 27 Oct 2026. Rating dates above are the agencies' action dates, which can be much older than the data date. This page is for information only. It is not investment advice, a credit rating or a recommendation to buy, sell or hold any security. Facts are taken from the issuer's own documents and the sources linked on this page; check them with the source before investing.
